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Abstract
Pneumonia is common in the elderly and clinical manifestations are frequently atypical. Pneumonia should be 
considered in any older person presenting with falls, confusion, incontinence, worsening comorbidities or a deterioration 
in functional status. The respiratory rate is the most reliable sign to alert the health carer to the presence of pneumonia. 
Therapy should follow the recommendations of the South African Pneumonia Guidelines. Prevention strategies include 
the prevention and management of aspiration, reduction in the use of neuroleptic medication, influenza vaccination, 
maintenance of oral hygiene, smoking cessation and possibly the use of the newer antiviral preparations. 
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Introduction 
Pneumonia is an infection involving the 
alveoli and bronchioles of the lung and 
may be caused by bacteria (including 
mycobacterium tuberculosis), viruses 
and some parasites. The estimated 
rates of hospitalisation for a primary 
diagnosis of influenza or pneumonia 
show a dramatic rise from 6.8 per 100 
000 person years in the age group 5-
49 years, to 219.5 per 100 000 person 
years in the age group 75-79 years. In 
the age group 85 years and older, the 
rate rises to >600 per 100 000 person 
years.1 
Recognising the context in which 
pneumonia occurs is vital, as the 
aetiology and management differ 
depending on the characteristics of 
the patient and the environment in 
which the infection occurs. The four 
most important contexts or settings in 
which pneumonia occurs are: 
•  Community-acquired pneumonia 
(CAP) in the fit elderly person, 
which can be managed according 
to standard guidelines. 
•  Community-acquired pneumonia in 
persons with significant comorbidi-
ties, functional dependence, poor 
nutritional state and/or cognitive 
impairment. In these patients, 
the clinical presentation is often 
atypical and mortality is up to 
30%. Response to appropriate 
therapy is often slower and the 
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course of the illness is complicated 
by delirium, further functional 
decline and exacerbation of co-
morbid diseases. The threshold 
for admission to hospital should 
be lowered and the need for 
rehabilitation after the acute illness 
should be assessed. 
•  Aspiration pneumonia is common 
in patients with stroke, vascular 
dementia and progressive neu-
rological disease, and in patients 
who are being tube fed. Aspiration is 
also common in frail institutionalised 
persons. 
•  Nursing home-acquired pneumo-
nia (NHAP) may occur in institu-
tionalised elderly persons. Preven-
tive strategies are especially 
important and the causative orga-
nisms may differ from CAP.     
Clinical presentation 
Older patients with pneumonia present 
with a mean of three fewer symptoms 
than their younger counterparts.2 The 
classical diagnostic triad of cough, 
fever and dyspnoea may only be 
present in fewer than 60% of patients. 
Atypical presentations in which pneu-
monia must be considered include:
• falls
• confusion/delirium
• new or worsening incontinence
•  worsening comorbidities (e.g. 
worsening cardiac failure) or dete-
riorating function in activities of 
daily living
The clinical signs may be misleading. 
The respiratory examination is 
often difficult in a frail, confused 
patient. Auscultation findings are 
unremarkable in 35% of patients. 
As a general rule, the older and 
more debilitated the patient, the 
more likely the classical pneumonia 
syndrome will manifest incompletely. 
A respiratory rate >20 breaths per 
minute is the earliest and most 
sensitive sign and may precede other 
signs by three to four days.3 This rate 
is also a useful indicator for nursing 
staff of cardio-respiratory disease in 
institutionalised patients. 
Pulse oximetry is a readily 
available and non-invasive means of 
assessing severity and determines 
a need for supplementary oxygen 
therapy. Radiology is important, but 
may become less specific because 
of concomitant illnesses such as 
chronic pulmonary disease, heart 
failure and underlying malignancy, 
which hamper interpretation. Follow-
up chest X-rays are not required 
routinely in patients who become 
asymptomatic and return to their pre-
pneumonia status.
The recommended blood tests 
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measurement of renal parameters. C-
reactive protein (CRP) is a sensitive, 
age-independent marker that de-
creases after a favourable treatment 
response. A CRP level of 100 mg/l 
or higher has been independently 
associated with mortality in older 
patients with pneumonia in the pri-
mary care setting.4 
An older person produces less 
sputum and coughs ineffectively, 
thus reliable sputum samples are 
rarely obtained. Similarly, routine 
blood cultures rarely contribute to the 
management of the older patient. 
Clinical features of pneumonia 
associated with a poorer prognosis 
and/or mortality in the elderly are 
listed in Table I.
Table I: Clinical features associated 
with a poor prognosis of pneumonia 
and/or mortality in the elderly 4,5
Aspiration pneumonia may have 
both anaerobic (20%) and aerobic 
organisms (80%) implicated in 
their aetiology; most are gram-
negative enterobacteriaceae.6 The 
role of clinically silent aspiration is 
being recognised increasingly in 
the frail elderly.7 So-called atypical 
pneumonia accounts for up to 28% of 
CAP. Organisms implicated include 
Legionella pneumophila (should be 
suspected in the case of a paucity 
of clinical signs with constitutional 
symptoms, myalgia and diarrhoea), 
Chlamydia pneumoniae, Coxiella 
burnetti and Mycoplasma pneu-
moniae. Chlamydia pneumoniae 
has also been implicated in NHAP 
outbreaks.6 
Infection with the Human Immuno-
deficiency Virus (HIV) does not 
spare the older population and 
Pneumocystis jiroveci (formerly 
pneumocystis carinii) pneumonia 
should be considered in the hypoxic 
HIV infected older person. In an older 
person, particularly if the patient 
is not responding to conventional/
standard therapy, tuberculosis must 
always be considered.
Treatment and referral guidelines
Management will depend on whether 
or not the patient is hospitalised. 
Patients who require hospital admis-
sion are those:
•  With a presence of any of the high-
risk features listed in Table I, or8
 - respiratory rate >30
 - pulse rate >90
 -  temperature <36.5 o C or >38.1 o C
 -  oxygen saturation ≤92% breathing 
room air
 -  feeding tube present (unless 
prior directive on end of life 
pneumonia)
 - drowsy or severe delirium; or
•  Whose home circumstances lack 
sufficient physical, social or financial 
resources to ensure adequate care, 
monitoring and compliance with 
treatment. 
If there is any doubt, it is generally pru-
dent to admit the patient. Regardless 
of the site of management, early 
treatment, which requires early re-
cognition, is associated with better 
outcomes. Antibiotics should be 
administered promptly.9 Suggested 
empiric antibiotic therapy should 
follow the recommendations of the 
South African Pneumonia Guide-
lines.10 Different first-line therapies 
are recommended for outpatient 
and nursing home patients, and 
for hospitalised patients. Recom-
mendations for severe cases, or if the 
response is poor, are similar for all 
categories of patients (see Table II).  
If aspiration is suspected, ensure 
that antibiotics cover for anaerobic 
organisms. Agents that provide 
adequate anaerobic cover include 
amoxicillin-clavulanate, metronidazole 
and clindamycin. A duration of anti-
 
•  Respiratory rate >30 breaths/    
    minute
•  Heart rate >125 beats/ minute
•  Altered mental status
•  Hypotension (systolic BP <90     
    mmHg)
•  History of dementia
•  CRP >100
•   Acute aggravation of co-
morbid chronic diseases, 
especially diabetes, cardiac, 
renal and liver.
Microbiology aspects 
The organisms most commonly impli-
cated as causal of pneumonia in the 
elderly are Streptococcus pneumo-
niae (58%), Haemophilus influenzae 
(14%), Klebsiella pneumoniae 
(0-4%), Moraxella catarrhalis (0-4%), 
enterobacteriaceae and staphylo-
coccus aureus (0-7%). However, the 
contribution of respiratory viruses is 
being recog-nised increasingly and 
up to 26% of hospital admissions may 
be caused by a virus. Respiratory 
viruses include influenza, respiratory 
syncytial virus, adenovirus and pa-
rainfluenza. Synergism between in-
fluenza infection and streptococcus 
pneumoniae infection has been 
recorded and may explain the in-
creased susceptibility to secondary 
pneumonia post-viral infection.
 
Outpatient and nursing home patients 
•  Moderately severe 
    pneumonia:
    -  High-dose amoxycillin-clavulante, or second- or third-generation  
       cephalosporin
•  Severe pneumonia or poor response to therapy: 
    -  Add erythromycin, clarithromycin, azithromycin or doxycycline, or    
       use a newer fluoroquinolone with enhanced anti-pneumococcal    
       cover (moxifloxacin or gatifloxacin)  
Hospitalised patients
•  Initial management: 
    -  Intravenous third-generation cephalosporin or amoxicillin-  
       clavulanate
•  Severe pneumonia or poor response to therapy:
    -  Add erythromycin, clarithromycin, azithromycin or doxycycline, 
       or use a newer fluoroquinolone   with enhanced anti-  
       pneumococcal cover (moxifloxacin or gatifloxacin)  
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biotic therapy of seven to 14 days 
is generally recommended, but this 
may need to be modified according 
to clinical response and the deve-
lopment of complications.5
Tuberculosis or tumour should be 
suspected in patients who are not 
responding to standard therapy. 
Even frail elderly patients tolerate 
bronchoscopy well and should be 
referred to a respiratory service if a 
diagnosis cannot be confirmed. The 
older patient may be at increased 
risk for antibiotic-related adverse 
drug events, which should determine 
which agent is selected for initial 
therapy, for example avoiding the 
use of gatifloxacin in older persons 
at risk of dysglycaemia.11 The use 
of aminoglycoside antibiotics is 
avoided in the older person.
With rising concerns of an imminent 
influenza pandemic, the role of the 
neuraminidase inhibitors zanamivir 
and oseltamivir may become 
increasingly important. Current evi-
dence shows that these therapies 
need to be initiated very early to be 
effective. Their conferred benefit 
appears to be that they reduce the 
time to the alleviation of symptoms by 
between 0.5 and two days. Additional 
emerging evidence indicates that 
they may reduce hospitalisation if 
given within 48 hours after the onset of 
symptoms.12 At present, these agents 
are not standard care and their cost 
efficacy has not been determined in 
the South African setting.
Additional management strategies 
of importance in an older person 
with pneumonia are attention to 
adequate nutrition and hydration, 
early mobilisation and, if function 
has declined after the acute phase, 
referral to a geriatric team for reha-
bilitation to limit permanent functional 
loss.
Prevention strategies
Aspiration can be reduced by mea-
sures that involve swallow training, 
dietary management, positioning 
and a review of pharmacological 
treatment the patient may be on. 
Recently attention has been drawn 
to excess mortality associated with 
neuroleptic medication usage in the 
older patient.13 Reasons for these 
deaths may be dysphagia and a 
decreased cough reflex induced by 
a neuroleptic-related impairment of 
dopamine metabolism.14 Referral to 
a speech therapist for evaluation 
and caregiver training are strongly 
recommended where aspiration is 
suspected. Nasogastric or percu-
taneous gastrostomy feeding tubes 
do not prevent aspiration and may 
predispose to it.6
Poor oral hygiene with dental plaque 
colonisation has been shown to be 
a potential reservoir for organisms 
that are implicated in pneumonia in 
the older person. Oral care has been 
shown to be of benefit in reducing 
the incidence of pneumonia in elderly 
nursing-home patients.6 Dental care 
should therefore continue to be 
promoted in older persons, regard-
less of their care setting.
Vaccination has the potential to 
reduce hospitalisation and mortality 
in older persons. Immunosenescence 
may result in an incomplete antibody 
response, which causes a lower 
efficacy of vaccination in the older 
patient. However, this response 
is offset by the higher incidence 
of illness and associated greater 
morbidity and mortality in these 
patients. 
Vaccination against influenza should 
be promoted. All older persons may 
benefit from vaccination, although 
the greatest benefit occurs in patients 
with high-risk medical conditions. 
For all older persons, approximately 
100 patients need to be vaccinated 
against influenza to prevent one all-
cause death or hospitalisation. In 
the higher risk group with chronic 
comorbidity, the number that need to 
be treated to prevent one all-cause 
death or hospitalisation drops to 
55.15 Another influenza vaccination 
strategy shown to be beneficial is 
to vaccinate healthcare workers and 
nursing home staff.2 Pneumococcal 
vaccination is controversial, as bene-
fit has been shown in observational 
studies, but not on a meta-analysis 
of clinical trials.16 At present there 
is insufficient evidence to dissuade 
recommending its use.
Since tobacco use increases the risk 
of pneumonia, all smokers should 
be given advice and help to cease 
smoking.
The neuraminidase inhibitors also 
have a role in prophylaxis against 
influenza. When used for seasonal 
prophylaxis in nursing homes, a 
92% reduction was found in the 
incidence of laboratory-confirmed 
influenza, even though the majority 
of the residents had received the 
appropriate vaccination for the 
season.12 In the South African context 
the most cost effective utilization of 
the neuraminidase inhibitors may be 
as post-exposure prophylaxis.
Conclusions 
Pneumonia is a common problem 
in the elderly. A diagnosis is often 
difficult as symptoms and signs 
may be atypical. A high index 
of suspicion and an awareness 
of the most reliable clinical and 
laboratory findings will result in 
the early institution of appropriate 
therapy and will lessen morbidity 
and mortality. Effective prevention 
strategies are available and should 
be implemented, particularly as the 
benefit of these strategies is greatest 
in the older high-risk patient. 
See CPD Questionnaire, page 50
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